A Study to Assess the Safety and Efficacy of Prograf and MR4 in Kidney Transplantation Patients

NCT00720265 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

135

Enrollment

INDUSTRY

Sponsor class

Conditions

Kidney Transplantation

Interventions

DRUG: Prograf
DRUG: MR4

Sponsor

Astellas Pharma Inc

Collaborators

[object Object]